Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Sievers

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Acta Neuropathologica Communications|January 7, 2023
Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndromeLéa Guerrini-Rousseau, Arnault Tauziède-Espariat, David Castel, et al.
Acta Neuropathologica Communications|January 15, 2025
Pediatric high-grade gliomas with concomitant RB1 and SETD2 alterations and Li-Fraumeni syndromeArnault Tauziède-Espariat, Marie Simbozel, Philipp Sievers, et al.
Acta Neuropathologica Communications|August 22, 2023
Diagnostic accuracy of a minimal immunohistochemical panel in at/rt molecular subtyping, correlated to dna-methylation profilingArnault Tauziède-Espariat, Julien Masliah-Planchon, Mamy Andrianteranagna, et al.
Acta Neuropathologica|June 30, 2022
Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expressionAndrey Korshunov, Konstantin Okonechnikov, Damian Stichel, et al.
Acta Neuropathologica Communications|October 30, 2021
A novel SMARCA2-CREM fusion: expanding the molecular spectrum of intracranial mesenchymal tumors beyond the FET genesArnault Tauziède-Espariat, Gaëlle Pierron, Delphine Guillemot, et al.
Acta Neuropathologica|August 27, 2024
Correlation between natural history and multi-omics profiling of meningiomas in NF2-related schwannomatosis suggests role of methylation group and immune microenvironment in tumor growth rateYu Teranishi, Andrey Yurchenko, Suzanne Tran, et al.
Acta Neuropathologica|April 24, 2023
Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypesAndrey Korshunov, Konstantin Okonechnikov, Daniel Schrimpf, et al.
Acta Neuropathologica|August 8, 2024
Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningiomaSybren L N Maas, Thomas Hielscher, Philipp Sievers, et al.
Nature Communications|March 15, 2026
Turn-on luminescence from molecular rotor realignment in metal-organic framework thin filmsJan C Fischer, Tong Zhou, Philipp Sievers, et al.
Neuro-Oncology|February 16, 2021
Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicatorAndrey Korshunov, Konstantin Okonechnikov, Damian Stichel, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica Communications|January 7, 2023
Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndromeLéa Guerrini-Rousseau, Arnault Tauziède-Espariat, David Castel, et al.
Acta Neuropathologica Communications|January 15, 2025
Pediatric high-grade gliomas with concomitant RB1 and SETD2 alterations and Li-Fraumeni syndromeArnault Tauziède-Espariat, Marie Simbozel, Philipp Sievers, et al.
Acta Neuropathologica Communications|August 22, 2023
Diagnostic accuracy of a minimal immunohistochemical panel in at/rt molecular subtyping, correlated to dna-methylation profilingArnault Tauziède-Espariat, Julien Masliah-Planchon, Mamy Andrianteranagna, et al.
Acta Neuropathologica|June 30, 2022
Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expressionAndrey Korshunov, Konstantin Okonechnikov, Damian Stichel, et al.
Acta Neuropathologica Communications|October 30, 2021
A novel SMARCA2-CREM fusion: expanding the molecular spectrum of intracranial mesenchymal tumors beyond the FET genesArnault Tauziède-Espariat, Gaëlle Pierron, Delphine Guillemot, et al.
Acta Neuropathologica|August 27, 2024
Correlation between natural history and multi-omics profiling of meningiomas in NF2-related schwannomatosis suggests role of methylation group and immune microenvironment in tumor growth rateYu Teranishi, Andrey Yurchenko, Suzanne Tran, et al.
Acta Neuropathologica|April 24, 2023
Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypesAndrey Korshunov, Konstantin Okonechnikov, Daniel Schrimpf, et al.
Acta Neuropathologica|August 8, 2024
Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningiomaSybren L N Maas, Thomas Hielscher, Philipp Sievers, et al.
Nature Communications|March 15, 2026
Turn-on luminescence from molecular rotor realignment in metal-organic framework thin filmsJan C Fischer, Tong Zhou, Philipp Sievers, et al.
Neuro-Oncology|February 16, 2021
Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicatorAndrey Korshunov, Konstantin Okonechnikov, Damian Stichel, et al.
Pageof 13